Chu D, Liu T, Yao Y
Front Microbiol. 2023; 14:1194431.
PMID: 37293236
PMC: 10244558.
DOI: 10.3389/fmicb.2023.1194431.
Bobadilla M, Villagra V, Ortiz V, Deluca G, de Paula V
PLoS One. 2023; 18(4):e0283542.
PMID: 37023094
PMC: 10079089.
DOI: 10.1371/journal.pone.0283542.
Ashaka O, Omoare A, James A, Adeyemi O, Oladiji F, Adeniji K
Trop Med Infect Dis. 2022; 7(11).
PMID: 36422937
PMC: 9692597.
DOI: 10.3390/tropicalmed7110386.
Donkoh E, Asmah R, Agyemang-Yeboah F, Dabo E, Wiredu E
Cancer Control. 2022; 29:10732748221094721.
PMID: 35536890
PMC: 9096183.
DOI: 10.1177/10732748221094721.
Debrah O, Agyemang-Yeboah F, Donkoh E, Asmah R
BMC Womens Health. 2021; 21(1):372.
PMID: 34702246
PMC: 8549380.
DOI: 10.1186/s12905-021-01511-1.
Human Papillomavirus (HPV) Prevalence and Type Distribution in Urban Areas of Malaysia.
Rahmat F, Kuan J, Hajiman Z, Mohamed Shakrin N, Che Roos N, Mustapa M
Asian Pac J Cancer Prev. 2021; 22(9):2969-2976.
PMID: 34582669
PMC: 8850893.
DOI: 10.31557/APJCP.2021.22.9.2969.
High-risk HPV genotypes in Zimbabwean women with cervical cancer: Comparative analyses between HIV-negative and HIV-positive women.
Kuguyo O, Mandishora R, Thomford N, Makunike-Mutasa R, Nhachi C, Matimba A
PLoS One. 2021; 16(9):e0257324.
PMID: 34582476
PMC: 8478215.
DOI: 10.1371/journal.pone.0257324.
Novel concepts in cervical cancer screening: a comparison of VIA, HPV DNA test and p16/Ki-67 dual stain cytology in Western Kenya.
Orango E, Were E, Rode O, Muthoka K, Byczkowski M, Sartor H
Infect Agent Cancer. 2020; 15:57.
PMID: 33024449
PMC: 7531147.
DOI: 10.1186/s13027-020-00323-6.
Whole-Genome Analysis of Cervical Human Papillomavirus Type 35 from rural Zimbabwean Women.
Fitzpatrick M, Hahn Z, Mandishora R, Dao J, Weber J, Huang C
Sci Rep. 2020; 10(1):7001.
PMID: 32332798
PMC: 7181610.
DOI: 10.1038/s41598-020-63882-z.
Prevalence, genotype distribution and risk factors of cervical HPV infection in Yangqu, China: a population-based survey of 10086 women.
Yang J, Wang W, Wang Z, Wang Z, Wang Y, Wang J
Hum Vaccin Immunother. 2019; 16(7):1645-1652.
PMID: 31809222
PMC: 7482860.
DOI: 10.1080/21645515.2019.1689743.
Spectrum of high risk human papillomavirus types in women in Kaduna State, Nigeria.
Magaji S, Aminu M, Inabo H, Oguntayo A
Ann Afr Med. 2019; 18(1):30-35.
PMID: 30729930
PMC: 6380112.
DOI: 10.4103/aam.aam_10_18.
Prevalence and Risk Factors for Genital Human Papillomavirus Infections Among Women in Southwest Nigeria.
Nejo Y, Olaleye D, Odaibo G
Arch Basic Appl Med. 2018; 6(1):105-112.
PMID: 29905313
PMC: 5997288.
Awareness of cervical cancer and willingness to be vaccinated against human papillomavirus in Mozambican adolescent girls.
Bardaji A, Mindu C, Augusto O, Casellas A, Cambaco O, Simbine E
Papillomavirus Res. 2018; 5:156-162.
PMID: 29665430
PMC: 6046684.
DOI: 10.1016/j.pvr.2018.04.004.
Prevalence of Specific Types of Human Papiloma Virus in Cervical Intraepithelial Lesions and Cervical Cancer in Macedonian Women.
Aleksioska-Papestiev I, Chibisheva V, Micevska M, Dimitrov G
Med Arch. 2018; 72(1):26-30.
PMID: 29416214
PMC: 5789568.
DOI: 10.5455/medarh.2018.72.26-30.
Human papillomavirus prevalence and genotype distribution among young women and men in Maputo city, Mozambique.
Edna Omar V, Orvalho A, Nalia I, Kaliff M, Lillsunde-Larsson G, Ramqvist T
BMJ Open. 2017; 7(7):e015653.
PMID: 28716790
PMC: 5722086.
DOI: 10.1136/bmjopen-2016-015653.
Differences in age-specific HPV prevalence between self-collected and health personnel collected specimen in a cross-sectional study in Ghana.
Awua A, Adanu R, Wiredu E, Afari E, Severini A
Infect Agent Cancer. 2017; 12:26.
PMID: 28529541
PMC: 5437497.
DOI: 10.1186/s13027-017-0136-7.
Randomized trial evaluating self-sampling for HPV DNA based tests for cervical cancer screening in Nigeria.
Modibbo F, Iregbu K, Okuma J, Leeman A, Kasius A, de Koning M
Infect Agent Cancer. 2017; 12:11.
PMID: 28184239
PMC: 5294803.
DOI: 10.1186/s13027-017-0123-z.
Molecular Characterization of High-Risk Human Papillomavirus in Women in Bobo-Dioulasso, Burkina Faso.
Traore I, Zohoncon T, Dembele A, Djigma F, Obiri-Yeboah D, Traore G
Biomed Res Int. 2016; 2016:7092583.
PMID: 27525275
PMC: 4971308.
DOI: 10.1155/2016/7092583.
Human papillomavirus (HPV) infection: a Mozambique overview.
Pizzol D, Putoto G, Chhaganlal K
Virusdisease. 2016; 27(2):116-22.
PMID: 27366761
PMC: 4909007.
DOI: 10.1007/s13337-016-0319-7.
Human papillomavirus infection in Rwanda at the moment of implementation of a national HPV vaccination programme.
Ngabo F, Franceschi S, Baussano I, Umulisa M, Snijders P, Uyterlinde A
BMC Infect Dis. 2016; 16:225.
PMID: 27221238
PMC: 4877733.
DOI: 10.1186/s12879-016-1539-6.